| risperidone / Generic mfg. |
NCT00249132: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia |
|
|
| Completed | 3 | 523 | US | risperidone | Janssen, LP | Schizophrenia, Psychotic Disorders | | 07/91 | | |
NCT00249119: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia |
|
|
| Completed | 3 | 1579 | US | risperidone | Janssen, LP | Schizophrenia, Psychotic Disorder | | 12/91 | | |
NCT00034762: Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease |
|
|
| Completed | 3 | 473 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Dementia, Alzheimer Disease, Mental Disorders | | 01/03 | | |
NCT00305422: Effect of Quetiapine on Negative Symptoms and Cognition |
|
|
| Completed | 3 | 45 | Europe | Quetiapine fumarate, Risperidone | AstraZeneca | Schizophrenia | | 01/03 | | |
NCT00236587: A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia |
|
|
| Completed | 3 | 100 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | | 02/04 | | |
NCT00297388: A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 3 | 40 | US | Risperidone, long-acting injectable | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Schizophrenia, Schizoaffective Disorder | | 09/04 | | |
NCT00283179: Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia |
|
|
| Completed | 3 | 83 | RoW | Aripiprazole, Risperidone | Taiwan Otsuka Pharm. Co., Ltd | Schizophrenia, Schizoaffective Disorder | | 12/04 | | |
NCT00034892: CAFE Comparison of Atypicals in First Episode of Psychosis |
|
|
| Completed | 3 | | US, Canada | Olanzapine, risperidone | AstraZeneca, University of North Carolina | Schizophrenia, Psychotic Disorders, Mental Health, Mental Disorders | 03/05 | 03/05 | | |
| Completed | 3 | 700 | Europe | Aripiprazole, Abilify, Olanzapine or Quetiapine or Risperidone | Otsuka Pharmaceutical Development & Commercialization, Inc., Otsuka America Pharmaceutical | Schizophrenia | 08/05 | 08/05 | | |
NCT00088075: Investigate Risperidone for the Treatment of Schizophrenia in Adolescents |
|
|
| Completed | 3 | 160 | US | Risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | | 12/05 | | |
NCT00034749: The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia |
|
|
| Completed | 3 | 279 | US | Risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | | 03/06 | | |
NCT00240708: A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia |
|
|
| Completed | 3 | 205 | Japan | risperidone | Janssen Pharmaceutical K.K. | Schizophrenia | | 04/06 | | |
NCT00246272: An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone |
|
|
| Completed | 3 | 82 | US | risperidone | Janssen-Ortho Inc., Canada | Schizophrenia | | 05/06 | | |
NCT00246285: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia |
|
|
| Completed | 3 | 381 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia, Psychotic Disorders | | 12/06 | | |
NCT00216580: A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis |
|
|
| Completed | 3 | 50 | Europe | Risperidone, long-acting injectable | Janssen Pharmaceutica N.V., Belgium | Schizophrenia | | 12/06 | | |
NCT00843687: A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients. |
|
|
| Completed | 3 | 188 | US | Risperidone long-acting injectable | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | 03/07 | 03/07 | | |
NCT01888107 / 2004-000830-35: Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 3 | 347 | Europe | Risperidone Long-acting Injectable (LAI) 25 mg, Risperidone LAI 37.5 mg, Risperidone LAI 50 mg | Janssen-Cilag S.p.A. | Schizophrenia, Schizoaffective Disorder | 04/07 | 04/07 | | |
NCT00174590: Treatment of Major Depressive Disorder With Psychotic Features. |
|
|
| Terminated | 3 | 30 | US | risperidone | Rush University Medical Center, Janssen, LP | Major Depression With Psychotic Features | | 08/07 | | |
| Completed | 3 | 9809 | Europe, RoW | Sertindole, Serdolect, Risperidone, Risperdal | H. Lundbeck A/S | Schizophrenia | 02/08 | 02/08 | | |
| Completed | 3 | 286 | US, Canada, Europe, RoW | Aripiprazole, Olanzapine, Risperidone, Quetiapine, Ziprasidone | Solvay Pharmaceuticals, H. Lundbeck A/S, Wyeth is now a wholly owned subsidiary of Pfizer | Schizophrenia and Schizoaffective Disorder | 02/08 | 02/08 | | |
NCT00366704: Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint |
|
|
| Terminated | 3 | 400 | US | bifeprunox, risperidone | Wyeth is now a wholly owned subsidiary of Pfizer, Solvay Pharmaceuticals | Schizophrenia | 03/08 | 03/08 | | |
| Terminated | 3 | 29 | Europe | Quetiapine, Seroquel, Risperidone, Risperdal | AstraZeneca | Schizophrenic Disorders | 12/08 | 12/08 | | |
NCT00604279: A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia |
|
|
| Completed | 3 | 452 | RoW | Paliperidone palmitate (R092670), Risperidone | Xian-Janssen Pharmaceutical Ltd. | Schizophrenia | 01/09 | 01/09 | | |
NCT00132314: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia |
|
|
| Completed | 3 | 382 | US | IM risperidone, oral antipsychotic medication | US Department of Veterans Affairs | Schizoaffective Disorder, Schizophrenia | 09/09 | 09/09 | | |
RECOVER, NCT00600756: Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone |
|
|
| Completed | 3 | 798 | Europe, RoW | Quetiapine XR, Seroquel XR, Risperidone, Risperdal | AstraZeneca | Schizophrenic Disorders | 10/09 | 10/09 | | |
| Completed | 3 | 216 | Europe | Quetiapine Extended Release, Seroquel XR™, Risperidone, Risperdal | AstraZeneca | Schizophrenia, Depression | 02/10 | 02/10 | | |
NCT00857818: Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome |
|
|
| Terminated | 3 | 64 | Canada | Aripiprazole, Abilify, BMS-334039, Oanzapine, risperidone, or quetiapine | Otsuka Pharmaceutical Development & Commercialization, Inc. | Schizophrenia, Schizoaffective Disorder, Bipolar I Disorder, Metabolic Syndrome | 03/10 | 03/10 | | |
NCT00641745: Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia |
|
|
| Completed | 3 | 629 | US, RoW | Lurasidone HCl, Risperidone | Sunovion | Schizophrenia, Schizoaffective Disorder | 07/10 | 07/10 | | |
|
NCT00435370: Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia |
|
|
| Completed | 3 | 179 | US, RoW | Tropisetron, Navoban, Placebo, Risperidone, Risperdal, Ridal, Rispolept | Baylor College of Medicine, National Institute of Mental Health (NIMH) | Smoking Cessation, Schizophrenia | 02/11 | 08/11 | | |
NCT01391403: Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia |
|
|
| Completed | 3 | 88 | RoW | Artemisinin, Qinghaosu, Placebo | Beijing HuiLongGuan Hospital, Stanley Medical Research Institute | Schizophrenia | 04/11 | 05/11 | | |
| Completed | 3 | 160 | Europe | Zicronapine, Past name: Lu 31-130, Risperidone, Risperdal® | H. Lundbeck A/S | Schizophrenia | 10/12 | | | |
NCT01516424: Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone |
|
|
| Completed | 3 | 267 | RoW | Blonanserin, Lonasen, Risperidone, Risperdal | Sumitomo Pharma (Suzhou) Co., Ltd. | Schizophrenia | 02/13 | 02/13 | | |
NCT00235352: Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia |
|
|
| Completed | 2/3 | 105 | US | CX516 (Ampakine) | North Suffolk Mental Health Association, RespireRx | Schizophrenia | 04/05 | 02/07 | | |
| Completed | 2/3 | 161 | RoW | Dextromethorphan | National Cheng-Kung University Hospital | Schizophrenia | 12/08 | 12/08 | | |
| Terminated | 2/3 | 1210 | Japan, US, RoW | LY2140023, mGlu 2/3 Prodrug II, Olanzapine, Zyprexa, LY170053, Aripiprazole, Risperidone, Quetiapine | Eli Lilly and Company | Schizophrenia | 10/12 | 10/12 | | |
